AI Tokens
Stock Analysis on Net

Cigna Group (NYSE:CI)

This company has been moved to the archive! The financial data has not been updated since February 27, 2025.

Enterprise Value to FCFF (EV/FCFF)

Microsoft Excel

Free Cash Flow to The Firm (FCFF)

Cigna Group, FCFF calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Shareholders’ net income 3,434 5,164 6,668 5,365 8,458
Net income attributable to noncontrolling interests 344 208 78 50 31
Net noncash charges 5,393 2,953 1,290 2,648 (1,737)
Net changes in assets and liabilities, net of non-operating effects 1,192 3,488 620 (872) 3,598
Net cash provided by operating activities 10,363 11,813 8,656 7,191 10,350
Interest paid, net of tax1 962 1,295 993 1,000 1,124
Property and equipment purchases, net (1,406) (1,573) (1,295) (1,154) (1,094)
Free cash flow to the firm (FCFF) 9,919 11,535 8,354 7,037 10,380

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).


The financial trajectory of cash flow generation over the five-year period ending December 31, 2024, is characterized by significant volatility, including a notable contraction in 2021, a strong recovery peaking in 2023, and a subsequent moderate decline in 2024.

Operating Cash Flow Trends
Net cash provided by operating activities experienced a sharp decline of approximately 30.5% between 2020 and 2021, dropping from US$ 10,350 million to US$ 7,191 million. This was followed by a consistent two-year upward trend, reaching a peak of US$ 11,813 million in 2023. The period concluded with a contraction in 2024, where cash flow retreated to US$ 10,363 million, returning to levels nearly identical to those seen in 2020.
Free Cash Flow to the Firm (FCFF) Analysis
FCFF mirrored the movements of operating cash flow with high precision. After a significant decrease to US$ 7,037 million in 2021, FCFF rose steadily to a five-year high of US$ 11,535 million in 2023. In 2024, FCFF declined to US$ 9,919 million. The volatility across the period indicates a fluctuation in the firm's ability to generate surplus cash available to all capital providers.
Cash Flow Correlation and Capital Intensity
A very high correlation is observed between net cash provided by operating activities and FCFF. The narrow variance between these two metrics suggests a capital-light operational structure, where capital expenditures and other investments required to maintain the firm's asset base represent a small fraction of the total cash generated from operations. This efficiency in converting operating cash into free cash flow remained consistent throughout the analyzed timeframe.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Interest Paid, Net of Tax

Cigna Group, interest paid, net of tax calculation

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Effective Income Tax Rate (EITR)
EITR1 28.30% 2.60% 19.20% 20.20% 21.90%
Interest Paid, Net of Tax
Interest paid, before tax 1,342 1,330 1,229 1,253 1,439
Less: Interest paid, tax2 380 35 236 253 315
Interest paid, net of tax 962 1,295 993 1,000 1,124

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 See details »

2 2024 Calculation
Interest paid, tax = Interest paid × EITR
= 1,342 × 28.30% = 380


An analysis of interest payments net of tax reveals a period of volatility between 2020 and 2024, characterized by a significant peak in 2023 followed by a reduction to a five-year low in 2024.

Interest Expenditure Trends
Interest payments net of tax decreased steadily from US$ 1,124 million in 2020 to US$ 993 million in 2022. This trend reversed sharply in 2023, with payments rising to US$ 1,295 million, representing the highest expenditure in the observed period. By December 31, 2024, the figure declined significantly to US$ 962 million.
Effective Income Tax Rate (EITR) Fluctuations
The EITR remained relatively stable between 2020 and 2022, ranging from 21.90% to 19.20%. A substantial contraction occurred in 2023, where the rate fell to 2.60%, before rebounding sharply to 28.30% in 2024, marking the highest rate recorded in the five-year window.
Interrelationship Between Tax Rates and Net Interest
The 2023 fiscal year is notable for the divergence between the EITR and net interest paid; despite a minimal tax shield of 2.60%, the net interest cost peaked at US$ 1,295 million, suggesting a significant increase in gross interest obligations. Conversely, in 2024, the combination of a higher EITR of 28.30% and a reduction in net interest paid to US$ 962 million indicates a more substantial tax benefit per dollar of interest paid alongside a likely reduction in overall debt service requirements.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?


Enterprise Value to FCFF Ratio, Current

Cigna Group, current EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Selected Financial Data (US$ in millions)
Enterprise value (EV) 106,870
Free cash flow to the firm (FCFF) 9,919
Valuation Ratio
EV/FCFF 10.77
Benchmarks
EV/FCFF, Competitors1
Abbott Laboratories 26.17
Elevance Health Inc. 20.60
Intuitive Surgical Inc. 64.76
Medtronic PLC 25.45
UnitedHealth Group Inc. 21.60
EV/FCFF, Sector
Health Care Equipment & Services 23.39
EV/FCFF, Industry
Health Care 31.62

Based on: 10-K (reporting date: 2024-12-31).

1 Click competitor name to see calculations.

If the company EV/FCFF is lower then the EV/FCFF of benchmark then company is relatively undervalued.
Otherwise, if the company EV/FCFF is higher then the EV/FCFF of benchmark then company is relatively overvalued.


Enterprise Value to FCFF Ratio, Historical

Cigna Group, historical EV/FCFF calculation, comparison to benchmarks

Microsoft Excel
Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Selected Financial Data (US$ in millions)
Enterprise value (EV)1 106,870 120,476 111,806 99,719 95,068
Free cash flow to the firm (FCFF)2 9,919 11,535 8,354 7,037 10,380
Valuation Ratio
EV/FCFF3 10.77 10.44 13.38 14.17 9.16
Benchmarks
EV/FCFF, Competitors4
Abbott Laboratories 35.21 36.51 23.24 23.47 —
Elevance Health Inc. 15.57 14.19 13.32 12.74 —
Intuitive Surgical Inc. 153.43 170.92 85.45 56.01 —
Medtronic PLC 20.58 26.54 20.32 33.84 —
UnitedHealth Group Inc. 20.57 17.59 19.30 22.21 —
EV/FCFF, Sector
Health Care Equipment & Services 25.57 22.68 20.44 23.51 —
EV/FCFF, Industry
Health Care 24.05 25.98 18.66 17.80 —

Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).

1 See details »

2 See details »

3 2024 Calculation
EV/FCFF = EV ÷ FCFF
= 106,870 ÷ 9,919 = 10.77

4 Click competitor name to see calculations.


An analysis of the financial metrics from 2020 to 2024 reveals a period of volatility in cash flow generation coupled with fluctuating enterprise valuations. The relationship between enterprise value and free cash flow to the firm indicates shifts in valuation multiples, primarily driven by variances in operational cash generation rather than steady growth in enterprise value.

Enterprise Value (EV) Trends
Enterprise value experienced a consistent upward trajectory from 2020 through 2023, rising from 95,068 million US$ to a peak of 120,476 million US$. This growth represented a total increase of approximately 26.7% over three years. However, this trend reversed in 2024, with the enterprise value declining to 106,870 million US$, signaling a contraction in the overall market valuation of the entity.
Free Cash Flow to the Firm (FCFF) Analysis
Free cash flow to the firm exhibited significant volatility during the period. A notable decline occurred in 2021, where FCFF dropped to 7,037 million US$ from 10,380 million US$ in 2020. This was followed by a steady recovery phase, peaking at 11,535 million US$ in 2023. By the end of 2024, FCFF decreased again to 9,919 million US$, returning to levels similar to those observed at the start of the five-year period.
EV/FCFF Ratio Interpretation
The EV/FCFF ratio peaked in 2021 at 14.17, a direct result of the simultaneous increase in enterprise value and a sharp contraction in free cash flow. Following this peak, the ratio trended downward to 10.44 by 2023 as cash flow generation improved and outpaced the growth of the enterprise value. The ratio remained relatively stable into 2024, ending at 10.77. This suggests that while the valuation multiple expanded significantly between 2020 and 2021, it has since normalized toward a lower baseline.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?